Aa Aa Aa

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines to meet the major unmet medical needs of patients on a global basis.

Find out more.


  • July 23, 2014

    Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone)

  • July 22, 2014

    Sucampo Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results and Corporate Update Teleconference and Webcast on August 5

  • July 7, 2014

    Swissmedic Approves AMITIZA(R) (Lubiprostone) for the Treatment of Opioid-Induced Constipation

  • June 17, 2014

    AMITIZA(R) (Lubiprostone) Receives NICE Recommendation